John Paul Clancy, MD

Professor of Pediatrics
Pediatric Pulmonary
Gregory Fleming James Cystic Fibrosis Research Center
University of Alabama at Birmingham
Birmingham, AL

Dr. Clancy is a Professor in the Department of Pediatrics at UAB, and the Director of the institutions’ CFFT-TDN Translation Research Center. He is the Director of the Pediatric Pulmonary Division, The Medical Director of the MCHB-funded Pediatric Pulmonary Center at UAB, and is the first recipient of the Raymond K. Lyrene Chair in Pediatric Pulmonology at the Children’s Hospital of Alabama. He is an expert in the development and conduct of CFTR modulator clinical and translational research. He has authored more than 150 publications, and serves a variety of leadership functions for the CFFT-TDN, CFF and NIH.

.............................................................................

Christopher H. Goss, MD, MS, FCCP

Associate Professor of Medicine
Pulmonary and Critical Care Medicine
University of Washington Medical Center
Seattle, WA

Dr. Goss is an Associate Professor of Medicine and Adjunct Associate Professor of Pediatrics at the University of Washington in Seattle.  He is also the Chief Medical Officer of the CF Foundation Therapeutics Development Network Coordinating Center in Seattle.  He has a Master of Epidemiology from the University of Washington.  His research focuses on clinical epidemiology in CF (survival and predictor of outcome), environmental factors influencing CF lung disease (i.e. air pollution), clincical trials in CF and development of outcome measures for CF clinical trials and clinical epidemiology (i.e. patient reported outcomes).  He has 51 publications, the majority of which are in the are of cystic fibrosis clinical research.

.............................................................................

Peter J. Mogayzel, Jr., MD, PhD
Program Director

Associate Professor of Pediatrics
Director, Cystic Fibrosis Center
Medical Director, Pediatric Lung Transplantation Program
Johns Hopkins Cystic Fibrosis Center
Baltimore, MD

Dr. Mogayzel has been the Director of the Cystic Fibrosis Center at Johns Hopkins Hospital since 2002 and Medical Director of the Pediatric Specialty Clinic since 2006. An Associate Professor of Pediatrics, he attended Brown University and received his M.D. and Ph.D. degrees from Boston University. He completed his pediatric residency at the University of Washington, and pediatric pulmonary and pediatric critical care fellowships at Johns Hopkins in 1998 before joining the faculty.

Dr. Mogayzel is a Fellow of American College of Chest Physicians and the American Academy of Pediatrics, and a member of several societies including the American Thoracic Society. The thrust of his research is the regulatory properties of the CFTR gene. Dr. Mogayzel serves as Co-chairman of the Clinical Practice Guidelines for Pulmonary Therapies Committee of the Cystic Fibrosis Foundation and Chairman of the Cystic Fibrosis Foundation Center Committee which accredits cystic fibrosis centers in the US.

.............................................................................

Richard B. Moss, MD

Professor of Pediatrics
Pulmonary Medicine
Director, Cystic Fibrosis Center
Center for Excellence in Pulmonary Biology
Stanford University Medical Center
Palo Alto, CA

Dr. Moss is Professor of Pediatrics, former Chief of the Allergy and Pulmonary Divisions in the Department of Pediatrics at Stanford University School of Medicine, and Director of the Stanford Cystic Fibrosis Center at Lucile Packard Children's Hospital at Stanford University Medical Center. He received his undergraduate degree from Columbia University in 1971 and medical degree from State University of New York at New York in 1975. He did pediatric residency training at Northwestern University Children's Memorial Hospital in Chicago. He continued postgraduate training with fellowships in allergy-immunology and pulmonology at Stanford University.

Dr. Moss has served on numerous external review agencies, including several study sections for the National Institutes of Health, and private agencies in the United States, Canada, and Europe. He has been a member of the Cystic Fibrosis Foundation Clinical Research Committee and chaired the Cystic Fibrosis Therapeutics Development Network Protocol Review Committee. In the course of his academic career his medical research has included laboratory and clinical studies of allergy, asthma, inflammation, immunologic and allergic aspects of cystic fibrosis, gene therapy, pulmonary delivery of drugs, biologics therapy with cytokines, and development of new outcome indicators using biomarkers and imaging. Dr. Moss is author of over 160 peer-reviewed papers dealing with allergy, immunodeficiency, asthma, bronchopulmonary dysplasia, cystic fibrosis, and other pulmonary topics.

.............................................................................

Meghan Ramsay, MS, CRNP
Program Director

Clinical Coordinator
Johns Hopkins Adult Cystic Fibrosis Program
Baltimore, MD

Meghan Ramsay has been with Johns Hopkins Hospital for 10 years, previously as a staff nurse and currently as a nurse practitioner.  She has been with the Adult Cystic Fibrosis Program for the past 3 years.  Meghan received her Bachelor of Science in Nursing from Valparaiso University.  Furthermore, she received her Master of Science in Nursing from Johns Hopkins University.  She is a certified nurse practitioner from the American Nurses Credentialing Center and is a current member of the Nurse Practitioner Association of Maryland.

.............................................................................

Pamela L. Zeitlin, MD, PhD

Professor of Pediatrics
Director, Pediatric Pulmonary
The Johns Hopkins University School of Medicine
Baltimore, MD

Pamela Zeitlin received a B.S. from Stanford University and the M.D. and Ph.D. from Yale University School of Medicine. She completed her pediatrics internship, residency and pediatric pulmonology fellowship at the Johns Hopkins Children’s Center. The focus of her research is gene and pharmacological therapies for cystic fibrosis.  She serves on a number of National Institutes of Health Studies Sections and is a member of the American Thoracic Society.